- ►diabetesjournals.org BJ Goldstein, MN Feinglos, JK Lunceford, J … - Diabetes Care, 2007 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—In a 24-week, randomized, double-blind,
placebo-controlled, parallel-group study, 1,091 patients with type 2 diabetes
and A1C 7.5–11% were randomized to one of six daily treatments: ... Cited by 96 - Related articles - BL Direct - All 9 versions
K Hermansen, M Kipnes, E Luo, D Fanurik, H … - Diabetes Obes Metab, 2007 - januvia.com Thank you for your interest in the enclosed reprint, “Efficacy and Safety of
the Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, in Patients With Type 2
Diabetes Mellitus Inadequately Controlled on Glimepiride Alone or on ... Cited by 76 - Related articles - View as HTML - All 5 versions
MA Nauck, G Meininger, D Sheng, L Terranella … - Diabetes, Obesity and Metabolism, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 133 - Related articles - All 7 versions
B Charbonnel, A Karasik, J Liu, M Wu, G … - Diabetes Care, 2006 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—After a screening diet/exercise run-in period, a
metformin dose titration/stabilization period, and a 2-week, single-blind,
placebo run-in period, 701 patients, aged 19–78 years, with mild to ... Cited by 204 - Related articles - BL Direct - All 9 versions
- ►januvia.se [PDF] I Raz, M Hanefeld, L Xu, C Caria, D Williams … - Diabetologia, 2006 - Springer Abstract Aims/hypothesis The aim of this study was to assess the efficacy and
safety of sitagliptin (MK-0431) as mono- therapy in patients with type 2
diabetes mellitus and inadequate glycaemic control (HbA 1c Q7% and e10%) on ... Cited by 167 - Related articles - All 5 versions
FD Care - medscape.com Since sitagliptin and metformin lower glucose concentrations through different,
but potentially complementary, mechanisms the initial combination of sitagliptin
and metformin should provide effective, potentially additive, glycemic ... Related articles - All 4 versions
P Aschner, MS Kipnes, JK Lunceford, M … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Sitagliptin 100 and 200 mg produced significant (P < 0.001)
placebo-subtracted reductions in A1C (−0.79 and −0.94%, respectively) and
fasting plasma glucose (−1.0 mmol/l [−17.1 mg/dl] and −1.2 mmol/l ... Cited by 195 - Related articles - BL Direct - All 13 versions
A Schweizer, A Couturier, JE Foley, S Dejager - Diabetic Medicine, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 90 - Related articles - BL Direct - All 4 versions
R Scott, T Loeys, MJ Davies, SS Engel… - Diabetes, obesity & metabolism, 2008 - ncbi.nlm.nih.gov Efficacy and safety of sitagliptin when added to ongoing metformin therapy in
patients with type 2 diabetes. ... Scott R, Loeys T, Davies MJ, Engel SS;
Sitagliptin Study 801 Group. ... Collaborators: Darnell D, Davis T, ... Cited by 30 - Related articles - All 2 versions
J Rosenstock, R Brazg, PJ Andryuk, K Lu, P … - Clinical therapeutics, 2006 - Elsevier This was a 24-week, multicenter, ran domized, double-blind, placebo-controlled,
parallel group study in patients aged ≥18 years (ClinicalTrials. gov
NCT00086502). At screening, all patients began a diet/exercise program that ... Cited by 164 - Related articles - All 4 versions
